Theratechnologies Inc. (TSE:TH - Get Free Report) passed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of C$3.69 and traded as high as C$4.30. Theratechnologies shares last traded at C$4.29, with a volume of 18,025 shares.
Analysts Set New Price Targets
Separately, Jones Trading cut shares of Theratechnologies from a "strong-buy" rating to a "hold" rating in a report on Thursday, July 3rd.
Check Out Our Latest Analysis on TH
Theratechnologies Trading Up 0.9%
The firm has a 50-day moving average price of C$3.75 and a 200-day moving average price of C$3.07. The company has a debt-to-equity ratio of -293.92, a quick ratio of 0.64 and a current ratio of 1.08. The stock has a market cap of C$138.15 million, a PE ratio of -49.01, a price-to-earnings-growth ratio of -8.50 and a beta of 1.73.
Theratechnologies Company Profile
(
Get Free Report)
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States.
Featured Articles
Before you consider Theratechnologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Theratechnologies wasn't on the list.
While Theratechnologies currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access